Phas Ii efficacy is scheduled to start in the 4th quarter. Results won't be seen until sometime in 2019 IMO. Positive results would give us something over $5.00 IMO
A good question that is hard to answer. As we know, successful completion of Phase II is what most BIG MONEY investors look forward to before investing in the company. So, it could go up A LOT like a few other MMJ companies.